eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
6/2018
vol. 35
 
Share:
Share:
more
 
 
abstract:
Original paper

Evaluation of the placebo effect in the trials of allergen immunotherapy effectiveness: meta-analysis of randomized and placebo-controlled trials

Michał Abramowicz, Jerzy Kruszewski, Andrzej Chciałowski

Adv Dermatol Allergol 2018; XXXV (6): 620-625
Online publish date: 2018/08/13
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
The total effect of the method of treatment is composed of its specific activity depending on its impact on the disease mechanism and the non-specific activity, i.e. the placebo effect. Many methods of treatment make use of such an inflammatory action.

Aim
To assess the placebo effect in the overall result of the specific immunotherapy and the analysis of its dependence on the type of specific immunotherapy, the disease, the age of a patient, the type of allergy, indicators used (objective and subjective), in patients with allergic diseases – asthma, allergic rhinitis and/or allergic conjunctivitis.

Material and Methods
A systematic review of Medline database was conducted using the EntrezPubmed search engine to find randomized placebo-controlled trials evaluating the effectiveness of specific immunotherapy in the treatment of asthma, allergic rhinitis and/or allergic conjunctivitis. After determining the contribution of the placebo effect for each of the test subjects, the calculation involved the average share of the placebo effect depending on the type of specific immunotherapy used, the type of disease, the age of the test subject, the type of allergy and the used measures of their effectiveness.

Results
The share of the placebo effect in the overall specific immunotherapy effect amounted to 39% and was comparable in the analyzed disease entities. A significantly higher share (p < 0.01) of 68% of the placebo effect in adult patients treated with sublingual immunotherapy vs. 29% in adult patients treated with subcutaneous immunotherapy.

keywords:

immunotherapy, placebo effect, meta-analysis

references:
Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Allergen immunotherapy: a practice parameter second update. J Allergy Clin Immunol 2007; 120: 25-85.
Dunbar WP. The present state of our knowledge of hay-fever. J Hyg (Lond) 1913; 13: 105-48.
Noon L, Cantab BC. Prophylactic inoculation against hay fever. Lancet 1911; 177: 1572-3.
Freeman J. Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine. Lancet 1911; 178: 814-7.
Frankland AW, Augustin R. Prophylaxis of summer hay-fever and asthma: a controlled trial comparing crude grass-pollen extracts with the isolated main protein component. Lancet 1954; 266: 1055-7.
Bousquet J, Khaltaev N, Cruzz AA, et al. Allergic Rhinitis and Its Impact on Asthma (ARIA 2008). Allergy 2008; 68: 8-160.
Radziwiłł K, Kruszewski J. Evaluation of the size of the placebo effect in treatments of allergic diseases and asthma based on a meta-analysis of efficacy trials of drugs. Post Dermatol Alergol 2011; 28: 372-7.
Radziwiłł K, Kruszewski J. Assessment of the size of the placebo effect in treating asthma based on meta-analysis of efficacy trials of selected antiasthmatic drugs. Pneumonol Alergol Pol 2012; 80: 301-7.
Narkus A, Lehnigk U, Haefner D, et al. The placebo effect in allergen-specific immunotherapy trials. Clin Transl Allergy 2013; 3: 42.
Dutile S, Kaptchuk TJ, Wechsler ME. The placebo effect in asthma. Curr Allergy Asthma Rep 2014; 14: 456.
Wedi B, Wieczorek D, Kapp A. Placebo effect in clinical trials with allergen-specific immunotherapy with inhalant allergens. Hautarzt 2017; 68: 297-306.
del Cuvillo A, Sastre J, Bartra J, et al. Placebo effect in clinical trials involving patients with allergic rhinitis. J Investig Allergol Clin Immunol 2011; 21 (Suppl 3): 40-5.
Zalewska-Janowska A. Psychodermatologia w alergologii. Alergia Astma Immunol 2010; 15: 109-17.
Kubik A, Skowronek-Bała B, Zajac A, Kaciński M. Placebo test in the diagnostics of pseudoepileptic seizures in children and adolescents. Przegl Lek 2004; 61: 1244-52.
De Craen AJ, Tijssen JG, De Gans J, Kleijnen J. Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos. J Neurol 2000; 247: 183-8.
Calderon MA, Eichel A, Makatsori M, Pfaar O. Comparability of subcutaneous and sublingual immunotherapy outcomes in allergic rhinitis clinical trials. Curr Opin Allergy Clin Immunol 2012; 12: 249-56.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe